These latest miraculous gains by Thibaudeau are a little contradictory because, while he’s said repeatedly on their forum that he could get much bigger if he wanted to, he’s also been saying that he doesn’t want to/can’t because of health issues (and I believe he also said that he only took steroids experiementally for a little while when he was a teenager). He clearly must have changed his mind, however, because he’s just claimed to have gained more muscle in 6 weeks than many drug-free bodybuilders of his stature gain in a lifetime of training. He’s doing very well – he’s now carrying over 40 pounds more muscle than the world’s best drug-free bodybuilding champions of his height (which is also well over twice as much muscle as they’ve managed to build).
Bortezomib, a boronic acid dipeptide, is a highly selective, reversible inhibitor of the 26S proteasome which primarily functions in the degradation of mis-folded proteins and is essential for the regulation of the cell cycle. Exposure to Bortezomib has been shown to stabilize p21, p27, and p53, as well as the proapoptotic Bid and Bax proteins, caveolin-1, and inhibitor κB-α, which prevents activation of nuclear factor κB-induced cell survival pathways. Bortezomib also promotes the activation of the proapoptotic c-Jun-NH2 terminal kinase, as well as the endoplasmic reticulum stress response. Alteration of the levels of these cellular proteins leads to inhibition of proliferation, migration, and promotion of apoptosis of cancer cells.  Bortezomib is shown to penetrate into cells and inhibit proteasome-mediated intracellular proteolysis of long-lived proteins with a concentration that inhibits 50% of the proteolysis of ∼ μM. The average growth inhibition of 50% value for Bortezomib across the entire panel of 60 cancer cell lines derived from multiple human tumors from the US National Cancer Institute (NCI) is 7 nM. Treatment of PC-3 cells with Bortezomib (100 nM) for 8 h results in the accumulation of cells in G2-M, with a corresponding decrease in the number of cells in G1. Bortezomib kills PC-3 cells at 24 and 48 hr with IC50 of 100 and 20 nM, respectively. Bortezomib induces nuclear condensation at 16–24 hr after treatment. Bortezomib treatment leads to PARP cleavage in a time-dependent manner with concentrations as low as 100 nM being effective at 24 hr. 
I used to think I could get rich off domain flipping. sold for $ million in 2003, and sold for $ million in 2012. I’ve since given up on the concept, opting to spend my time purchasing domains for inside jokes rather than retirement plan gambles. While I’m pretty sure you won’t get as lucky as (a cool $13 million) you can still score a pretty cool one thanks to 😁.to , a site created by BetaList founder Marc Köhlbrugge offering an easy way to purchase emoji-based domain names, and see which ones have been snatched up.